175 related articles for article (PubMed ID: 16037679)
1. Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis.
Sakairi T; Suzuki K; Makita S; Wajima T; Shakuto S; Yoshida Y; Yaguchi M
Pharmacology; 2005 Oct; 75(2):76-86. PubMed ID: 16037679
[TBL] [Abstract][Full Text] [Related]
2. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis.
Yamasaki M; Mizutani N; Sasaki K; Nabe T; Matsumoto T; Ashida Y; Kohno S
Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852
[TBL] [Abstract][Full Text] [Related]
3. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model.
Akiyama K; Karaki M; Kobayshi R; Dobashi H; Ishida T; Mori N
Int Arch Allergy Immunol; 2009; 149(4):315-22. PubMed ID: 19295235
[TBL] [Abstract][Full Text] [Related]
4. Effects of a specific cysteinyl leukotriene antagonist, pranlukast, on antigen-induced cysteinyl leukotriene-mediated rhinitis in guinea pigs.
Fujita M; Yonetomi Y; Takeda H; Nakagawa N; Kawabata K; Ohno H
Jpn J Pharmacol; 1997 Dec; 75(4):347-53. PubMed ID: 9469640
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the leukocyte kinetics after intranasal antigen challenge in a guinea pig model of allergic rhinitis.
Yamasaki ML; Sasaki K; Mizutani N; Nabe T; Sakura Y; Matsumoto T; Ashida Y; Kohno S
Inflamm Res; 2001 Sep; 50(9):474-82. PubMed ID: 11603853
[TBL] [Abstract][Full Text] [Related]
6. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
7. Effects of KP-496, a novel dual antagonist of leukotriene D(4) and thromboxane A (2) receptors on nasal blockage in guinea pig models of allergic rhinitis.
Mizutani N; Suda M; Ishimura M; Kurokawa S; Nabe T; Kohno S
Inflamm Res; 2008 Jun; 57(6):247-51. PubMed ID: 18516714
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.
Suzuki Y; Inoue T; Yamamoto A; Sugimoto Y
Biol Pharm Bull; 2011; 34(4):507-10. PubMed ID: 21467637
[TBL] [Abstract][Full Text] [Related]
9. Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis.
Aoyagi H; Kajiwara D; Tsunekuni K; Tanaka K; Miyoshi K; Hirasawa N
Eur J Pharmacol; 2020 May; 875():173030. PubMed ID: 32084417
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase-2 in allergic nasal inflammation in rats.
Rahman A; Yatsuzuka R; Jiang S; Ueda Y; Kamei C
Int Immunopharmacol; 2006 Nov; 6(11):1736-42. PubMed ID: 16979129
[TBL] [Abstract][Full Text] [Related]
11. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis.
Schäper C; Gustavus B; Koch B; Ewert R; Hanf G; Kunkel G; Noga O; Gläser S
J Investig Allergol Clin Immunol; 2009; 19(6):459-64. PubMed ID: 20128420
[TBL] [Abstract][Full Text] [Related]
12. Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors.
Kayasuga R; Sugimoto Y; Watanabe T; Kamei C
Eur J Pharmacol; 2002 Aug; 449(3):287-91. PubMed ID: 12167471
[TBL] [Abstract][Full Text] [Related]
13. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.
Cingi C; Gunhan K; Gage-White L; Unlu H
Laryngoscope; 2010 Sep; 120(9):1718-23. PubMed ID: 20717951
[TBL] [Abstract][Full Text] [Related]
15. Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs.
Narita S; Asakura K; Kataura A
Int Arch Allergy Immunol; 1996 Feb; 109(2):161-6. PubMed ID: 8563491
[TBL] [Abstract][Full Text] [Related]
16. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
17. Participation in cysteinyl leukotrienes and thromboxane A2 in nasal congestion model in Brown Norway rats.
Kishi Y; Nakano Y; Jiang S; Yatsuzuka R; Kamei C
Int Immunopharmacol; 2007 Nov; 7(11):1483-7. PubMed ID: 17761352
[TBL] [Abstract][Full Text] [Related]
18. Effects of a cysteinyl leukotriene antagonist, ONO-1078 (pranlukast), on total airway resistance after antigen challenge in sensitized guinea pigs.
Narita S; Asakura K; Shirasaki H; Kataura A
Inflamm Res; 1997 Apr; 46(4):143-6. PubMed ID: 9137993
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs.
Fujita M; Yonetomi Y; Shimouchi K; Takeda H; Aze Y; Kawabata K; Ohno H
Eur J Pharmacol; 1999 Mar; 369(3):349-56. PubMed ID: 10225374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
